Organovo Holdings Inc (4OR1)

2.916
-0.214(-6.84%)
  • Volume:
    250
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    2.900 - 2.916
  • Type:Equity
  • Market:Germany
  • ISIN:US68620A2033
  • WKN:A2QA6Q

4OR1 Overview

Prev. Close
3.13
Day's Range
2.9-2.916
Revenue
-
Open
2.9
52 wk Range
2.9-19.25
EPS
-0.63
Volume
250
Market Cap
23.56M
Dividend (Yield)
0.00
(0.00%)
Average Vol. (3m)
557
P/E Ratio
-
Beta
-
1-Year Change
-74.34%
Shares Outstanding
8,705,408
Next Earnings Date
-
What is your sentiment on Organovo Holdings Inc?
or
Market is currently closed. Voting is open during market hours.

Organovo Holdings Inc Company Profile

Employees
11

Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. NovoGen Bioprinters can dispense pure hydrogel formulations and also serve as important components of company's tissue prototyping and manufacturing platform. The Company also intends to use its bioprinting platform as well as 3D technologies to treat its target diseases.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • This Stock will be fly!!! Today is earning day!
    0
    • Guys check CELLINK, great swedish 3D bioprinting company with big growth year after year.
      0
      • What kind of garbage stock is this?
        0
        • ramping................????'
          1
          • any idea why onvo is ramping up last few days? dont see any news
            1
            • 500 by 2030, my bet😶
              2
              • adjustments for inflation at the current price would get us there.
                1
            • buy?
              1
              • zombie company. shouldn't exist
                0
                • yes ato invest on zombie companies
                  1
                • yes ark investment have stake on it and you know better
                  1
              • Buy after the open
                1
                • Is it good idea to buy after opening? As I see selling price is already down 7-8% in Europe traders.
                  1
                • I think a Market buy when it hits the bottom may be the safedt bet but
                  1
                • Whats your plan
                  1
              • Any issue about delisting? I heard that rumor somewhere....
                1
                • hm....
                  1
                  • patience = gains
                    1
                    • I hope patients equals gains, I have my doubts about organovo
                      1
                  • Buyers for the IP and technology not for earnings. huge advancements in 3D printing human tissue. in due time will come earning to drive the stock price to values you could imagine.
                    2
                    • I hope you're right, you must have a better crystal ball that I do. let's keep our fingers crossed, in the meantime it's a good time to buy more
                      0
                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.